NCT02476435View on ClinicalTrials.gov

Depersonalization Disorder: Therapeutic Effect of Neuronavigated Repetitive Transcranial Stimulation

NACompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

June 19, 2015

Primary Completion Date

October 10, 2022

Study Completion Date

October 10, 2022

Conditions
Depersonalization Disorder
Interventions
DEVICE

Active rTMS

Strong electromagnetic fields (\~2Tesla) generated briefly but repetitively (1Hz) applied for 30mins, in five sessions per week for 3 weeks

DEVICE

Placebo rTMS

Placebo electromagnetic fields generated briefly but repetitively applied for 30mins, in five sessions per week for 3 weeks

Trial Locations (2)

75012

Saint-Antoine Hospital, Paris

75014

Centre Hospitalier Sainte-Anne, Paris

All Listed Sponsors
lead

Centre Hospitalier St Anne

OTHER

NCT02476435 - Depersonalization Disorder: Therapeutic Effect of Neuronavigated Repetitive Transcranial Stimulation | Biotech Hunter | Biotech Hunter